STAT+: 5 years after lupus breakthrough, CAR-T is still surprising autoimmunity researchers
CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.
CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.
Researchers have found in a new study that high-frequency oscillatory ventilation (HFOV) may reduce the incidence of bronchopulmonary dysplasia (BPD) compared to conventional mechanical ventilation (CMV) in infants born at…
Researchers have found in a new study that among postmenopausal women, a higher Oxidative Balance Score (OBS)—reflecting a healthy diet and lifestyle—is associated with better periodontal health. Conversely, a low…
In this edition of Health Tech: FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.
Steve Ubl, chief executive of PhRMA, plans to step down at the end of the year, after more than a decade leading the main trade group for brand-name drug makers
The traditional biotech venture model under pressure, PhRMA chief Ubl to exit, and other biotech news from The Readout
Bengaluru: In the matter of MBBS bond service, the Karnataka High Court recently observed that the medicos cannot be permitted to challenge the obligation after completion of the entire course…
Lucknow: The Indian Medical Association (IMA), Uttar Pradesh unit, has expressed concerns that many patients in the state initially seek treatment from unqualified practitioners before consulting registered medical professionals, which…
Ludhiana: The Drug Control Department (DCD) has intensified its crackdown on illegal pharmaceutical stockpiling, leading to the detection of a firm in Ludhiana found storing nine varieties of allopathic medicines…
Bengaluru: Gilead said on Tuesday it would acquire Germany-based Tubulis GmbH for up to USD 5 billion, as it looks to strengthen its cancer drugs pipeline.This marks the latest in…